|
US5133974A
(en)
*
|
1989-05-05 |
1992-07-28 |
Kv Pharmaceutical Company |
Extended release pharmaceutical formulations
|
|
US5348945A
(en)
|
1990-04-06 |
1994-09-20 |
Wake Forest University |
Method of treatment with hsp70
|
|
EP0700445B1
(en)
|
1993-06-04 |
2002-01-23 |
Whitehead Institute For Biomedical Research |
Stress proteins and uses therefor
|
|
EP0751957B1
(en)
|
1994-03-21 |
2004-02-25 |
Rijksuniversiteit Utrecht |
Peptide fragments of microbial stress proteins and pharmaceutical composition made thereof for the treatment and prevention of inflammatory diseases
|
|
US5837251A
(en)
|
1995-09-13 |
1998-11-17 |
Fordham University |
Compositions and methods using complexes of heat shock proteins and antigenic molecules for the treatment and prevention of neoplastic diseases
|
|
US5985270A
(en)
|
1995-09-13 |
1999-11-16 |
Fordham University |
Adoptive immunotherapy using macrophages sensitized with heat shock protein-epitope complexes
|
|
US5935576A
(en)
|
1995-09-13 |
1999-08-10 |
Fordham University |
Compositions and methods for the treatment and prevention of neoplastic diseases using heat shock proteins complexed with exogenous antigens
|
|
HU222994B1
(hu)
|
1995-11-02 |
2004-01-28 |
BIOREX Kutató és Fejlesztő Rt. |
Hidroxilaminszármazékok és azok alkalmazása sejtek molekuláris chaperon-termelésének fokozására alkalmas gyógyszerkészítmények előállítására
|
|
US5962313A
(en)
|
1996-01-18 |
1999-10-05 |
Avigen, Inc. |
Adeno-associated virus vectors comprising a gene encoding a lyosomal enzyme
|
|
EP0950061A4
(en)
|
1996-09-20 |
2000-04-12 |
Univ New Mexico |
Heat shock protein complexes
|
|
US7157089B1
(en)
|
1996-11-26 |
2007-01-02 |
Stressgen Biotechnologies Corporation |
Immune responses using compositions containing stress proteins
|
|
US5830464A
(en)
|
1997-02-07 |
1998-11-03 |
Fordham University |
Compositions and methods for the treatment and growth inhibition of cancer using heat shock/stress protein-peptide complexes in combination with adoptive immunotherapy
|
|
US6017540A
(en)
|
1997-02-07 |
2000-01-25 |
Fordham University |
Prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases with heat shock/stress protein-peptide complexes
|
|
RS49982B
(sr)
*
|
1997-09-17 |
2008-09-29 |
Euro-Celtique S.A., |
Sinergistička analgetička kombinacija analgetičkog opijata i inhibitora ciklooksigenaze-2
|
|
US6007821A
(en)
|
1997-10-16 |
1999-12-28 |
Fordham University |
Method and compositions for the treatment of autoimmune disease using heat shock proteins
|
|
US5948646A
(en)
|
1997-12-11 |
1999-09-07 |
Fordham University |
Methods for preparation of vaccines against cancer comprising heat shock protein-peptide complexes
|
|
AU2337499A
(en)
|
1998-01-23 |
1999-08-09 |
National Jewish Medical And Research Center |
Method for treating inflammatory diseases using heat shock proteins
|
|
ES2355483T3
(es)
|
1998-02-20 |
2011-03-28 |
University Of Miami |
Complejo de proteina de choque térmico modificada-péptido antigénico.
|
|
WO1999049881A2
(de)
|
1998-03-27 |
1999-10-07 |
Gabriele Multhoff |
Verwendung von hsp70 protein
|
|
FR2777890B1
(fr)
|
1998-04-22 |
2000-12-29 |
Roussy Inst Gustave |
Composes peptidiques d'hsp70 utiles dans l'immunotherapie du cancer
|
|
US6274597B1
(en)
|
1998-06-01 |
2001-08-14 |
Mount Sinai School Of Medicine Of New York University |
Method of enhancing lysosomal α-Galactosidase A
|
|
US6475490B1
(en)
|
1998-10-19 |
2002-11-05 |
Fordham University |
Compositions and methods for promoting tissue repair using heat shock proteins
|
|
HU226617B1
(en)
|
1998-12-14 |
2009-04-28 |
Cytrx Corp |
Optically active pyridyl-4h-1,2,4-oxadiazine derivatives, and pharmaceutical composition containing the compound as active ingredient
|
|
HUP9900475D0
(en)
*
|
1999-02-26 |
1999-04-28 |
Biorex Kutato Fejlesztoe Kft |
O-(3-piperidino-2-hydroxy-1-propyl)-hiyroximic acid-halogenid derivative, it's use for treating insulin resistance, and pharmaceutical compositions containing them as active component
|
|
EP1218030A4
(en)
|
1999-09-10 |
2004-09-15 |
Univ Fordham |
METHODS AND COMPOSITIONS FOR TREATING AND PREVENTING TRANSPLANT REJECTION BY USING HEAT SHOCK PROTEINS
|
|
US20020039583A1
(en)
|
1999-09-30 |
2002-04-04 |
Subjeck John R. |
Stress protein compositions and methods for prevention and treatment of cancer and infectious disease
|
|
US20030236300A1
(en)
|
1999-10-27 |
2003-12-25 |
Yale University |
Conductance of improperly folded proteins through the secretory pathway and related methods for treating disease
|
|
WO2001034184A2
(en)
|
1999-11-05 |
2001-05-17 |
The Board Of Regents Of The University Of Nebraska |
Methods and compositions for protection against bovine herpesvirus 1
|
|
US6964851B2
(en)
|
1999-12-07 |
2005-11-15 |
Stressgen Biotechnologies Corp. |
Compositions and methods for detecting stress-inducible proteins
|
|
GB9930443D0
(en)
|
1999-12-22 |
2000-02-16 |
King S College London |
Novel use of heat shock proteins
|
|
US20020127219A1
(en)
|
1999-12-30 |
2002-09-12 |
Okkels Jens Sigurd |
Lysosomal enzymes and lysosomal enzyme activators
|
|
US20010034042A1
(en)
|
2000-01-20 |
2001-10-25 |
Srivastava Pramod K. |
Complexes of peptide-binding fragments of heat shock proteins and their use as immunotherapeutic agents
|
|
AU2001227960A1
(en)
|
2000-01-21 |
2001-07-31 |
University Of Connecticut Health Center |
Heat shock/stress protein complexes as vaccines against neurodegenerative disorders
|
|
AU2001229597A1
(en)
|
2000-01-21 |
2001-07-31 |
University Of Connecticut Health Center |
Compositions and methods to treat neurodegenerative disorders
|
|
HUP0001583A2
(hu)
|
2000-04-18 |
2002-11-28 |
BIOREX Kutató és Fejlesztő Rt. |
Egy piridin-1-oxid-származék és eljárás annak átalakítására gyógyászati hatású vegyületekké
|
|
US20020095135A1
(en)
|
2000-06-19 |
2002-07-18 |
David Meeker |
Combination enzyme replacement, gene therapy and small molecule therapy for lysosomal storage diseases
|
|
AU2001277961A1
(en)
|
2000-08-07 |
2002-02-18 |
Antigenics, Llc |
Compositions comprising heat shock proteins or alpha(2)macroglobulin, antigenic molecules and saponins, and methods of use thereof
|
|
ES2326114T3
(es)
|
2000-09-13 |
2009-10-01 |
Multimmune Gmbh |
Un peptido de hsp70 estimulador de la actividad de las celulas asesinas naturales (nk) y los usos del mismo.
|
|
AU2001292674A1
(en)
|
2000-09-15 |
2002-04-29 |
University Of Connecticut Health Center |
Improved formulations using heat shock/stress protein-peptide complexes
|
|
US20020172682A1
(en)
|
2000-10-20 |
2002-11-21 |
University Of Connecticut Health Center |
Using heat shock proteins to increase immune response
|
|
IT1319277B1
(it)
|
2000-10-24 |
2003-09-26 |
Chiesi Farma Spa |
Proteine di fusione utili per il trattamento di immunizzazione dellamalattia di alzheimer.
|
|
AU2002239462A1
(en)
|
2000-11-03 |
2002-06-03 |
The Board Of Regents Of The University Of Nebraska |
Compositions for protection against bovine viral diseases
|
|
EP1209226A3
(en)
|
2000-11-07 |
2002-06-05 |
GSF-Forschungszentrum für Umwelt und Gesundheit GmbH |
Maturation of dendritic cells by recombinant heat shock protein 70 (hsp70)
|
|
US20020142299A1
(en)
|
2001-01-09 |
2002-10-03 |
Davidson Beverly L. |
PTD-modified proteins
|
|
CA2438750A1
(en)
|
2001-02-20 |
2002-08-29 |
Uab Research Foundation |
Aminoglycoside treatment for lysosomal storage diseases
|
|
HK1079705A1
(zh)
|
2001-08-20 |
2006-04-13 |
University Of Connecticut Health Center |
包含用於治疗癌症及感染性疾病的热休克蛋白或α2-巨球蛋白的组合物制备方法
|
|
EP1430076A2
(en)
|
2001-09-27 |
2004-06-23 |
I.D.M. Immuno-Designed Molecules |
Polypeptides derived from inducible hsp70 and pharmaceutical compositions containing the same
|
|
HU0103939D0
(en)
*
|
2001-09-27 |
2001-11-28 |
Biorex Kutato Fejlesztoe Kft |
Pharmaceutical composition containing methformin and n-[2-hydroxy-3-(1-piperidinyl)-propoxy]-pyridine-1-oxide-3-carboximidoyl chloride
|
|
GB0123756D0
(en)
|
2001-10-03 |
2001-11-21 |
King S College London |
A novel chaperone-type of adjuvant for vaccination - Basic 1
|
|
US7125843B2
(en)
|
2001-10-19 |
2006-10-24 |
Neose Technologies, Inc. |
Glycoconjugates including more than one peptide
|
|
ITMI20012573A1
(it)
|
2001-12-06 |
2003-06-06 |
D B P Dev Biotechonologica L P |
Gli acilsalicilati:una nuova classe di induttori di risposta heat shock
|
|
WO2003057664A1
(en)
|
2002-01-11 |
2003-07-17 |
Biorex Kutató És Fejlesztö Rt. |
Carboxamidine derivatives and their use in the treatment of vascular diseases
|
|
AU2003218639A1
(en)
|
2002-01-24 |
2003-09-02 |
Universiteit Gent |
Tumour treatment compositions comprising hsp70 and tumour necrosis factor
|
|
AU2003216288B2
(en)
|
2002-02-13 |
2009-09-24 |
Duke University |
Modulation of immune response by non-peptide binding stress response polypeptides
|
|
IL148401A0
(en)
|
2002-02-26 |
2002-09-12 |
Hadasit Med Res Service |
Hsp70-derived peptides and uses thereof in the diagnosis and treatment of autoimmune diseases
|
|
US7658916B2
(en)
|
2002-04-05 |
2010-02-09 |
Genzyme Corporation |
Methods of enhancing lysosomal storage disease therapy by modulation of cell surface receptor density
|
|
US6984389B2
(en)
|
2002-04-25 |
2006-01-10 |
University Of Connecticut Health Center |
Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality
|
|
AU2003231098A1
(en)
|
2002-04-25 |
2003-11-10 |
University Of Connecticut Health Center |
Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality
|
|
CN1665533A
(zh)
|
2002-05-02 |
2005-09-07 |
康涅狄格大学健康中心 |
热激蛋白用于增强抗体疗法功效的用途
|
|
CA2483925A1
(en)
|
2002-05-02 |
2004-04-29 |
University Of Connecticut Health Center |
Using heat shock proteins and alpha-2-macroglobulins to increase immune response to vaccines comprising heat shock protein-peptide complexes or alpha-2-macroglobulin-peptide complexes
|
|
AU2003291625B2
(en)
|
2002-09-16 |
2009-10-08 |
Genentech, Inc. |
Compositions and methods for the treatment of immune related diseases
|
|
ES2396231T3
(es)
|
2003-05-21 |
2013-02-20 |
Biotech Tools S.A. |
Complejo peptídico
|
|
US7244616B2
(en)
|
2003-06-27 |
2007-07-17 |
Bayer Pharmaceuticals Corporation |
Use of molecular chaperones for the enhanced production of secreted, recombinant proteins in mammalian cells
|
|
HUP0303584A3
(en)
|
2003-10-30 |
2009-12-28 |
Cytrx Corp |
Use of a hydroximic acid halide derivative in the treatment of neurodegenerative diseases
|
|
EP1531160B1
(en)
|
2003-11-12 |
2010-12-29 |
Alfa Biogene International B.V. |
Recovery of a heat shock protein
|
|
CN1897957A
(zh)
|
2003-11-25 |
2007-01-17 |
纽约大学西奈山医学院 |
尼曼－皮克病的基于陪伴分子的治疗
|
|
US7700737B2
(en)
|
2003-12-05 |
2010-04-20 |
Multimmune Gmbh |
Therapeutic and diagnostic anti-Hsp70 antibodies
|
|
JP2005306778A
(ja)
|
2004-04-21 |
2005-11-04 |
Basf Ag |
徐放性製剤及びその製造方法
|
|
WO2005102272A2
(en)
*
|
2004-04-21 |
2005-11-03 |
Pfizer Products Inc. |
Sustained-release dosage forms for cabergoline
|
|
US20060009520A1
(en)
|
2004-05-12 |
2006-01-12 |
Tall Alan R |
Retinoid-based methods for altering macrophage cholesterol
|
|
WO2005120558A2
(en)
|
2004-05-25 |
2005-12-22 |
University Of Connecticut Health Center |
Methods for making compositions comprising heat shock proteins or alpha-2-macroglobulin for the treatment of cancer and infectious disease
|
|
US7270305B2
(en)
|
2004-06-15 |
2007-09-18 |
The Boeing Company |
Aircraft leading edge apparatuses and corresponding methods
|
|
UA88477C2
(ru)
|
2004-08-13 |
2009-10-26 |
Бёрингер Ингельхайм Интернациональ Гмбх |
Композиция пеллеты пролонгированного высвобождения, которая содержит прамипексол или его фармацевтически приемлемую соль, способ ее изготовления и ее применение
|
|
WO2006062402A2
(en)
|
2004-12-10 |
2006-06-15 |
Zernike Business Support B.V. |
Heat shock proteins (hsp) and supraventricular arrhythmia
|
|
ES2485369T3
(es)
|
2005-06-08 |
2014-08-13 |
Amicus Therapeutics, Inc. |
Tratamiento de trastornos del SNC asociados con mutaciones en genes que codifican enzimas lisosómicas
|
|
WO2007041285A2
(en)
|
2005-09-29 |
2007-04-12 |
Viral Genetics, Inc. |
Complexes of inactivated pepsin fraction and heat shock protein
|
|
PT2404919E
(pt)
|
2005-11-08 |
2013-10-22 |
Vertex Pharma |
Composto heterocíclico útil como um modulador de transportadores de cassete de ligação a atp
|
|
US20080039400A1
(en)
|
2006-01-24 |
2008-02-14 |
Universiteit Utrecht Uu Holding B.V. |
Treatment and prevention of inflammatory bowel diseases
|
|
WO2007089548A2
(en)
|
2006-01-26 |
2007-08-09 |
Foldrx Pharmaceuticals, Inc. |
Compounds and methods for modulating protein trafficking
|
|
JP2009537179A
(ja)
|
2006-05-19 |
2009-10-29 |
ザ スクリップス リサーチ インスティテュート |
蛋白質ミスフォールディングの処置
|
|
DK2040548T3
(da)
|
2006-06-23 |
2012-08-13 |
Amicus Therapeutics Inc |
Fremgangsmåde til behandling af neurologiske forstyrrelser ved forøgelse af aktiviteten af beta-glucocerebrosidase
|
|
ES2645095T3
(es)
|
2006-06-30 |
2017-12-04 |
Sloan-Kettering Institute For Cancer Research |
Tratamiento de enfermedades neurodegenerativas a través de la inhibición de Hsp90
|
|
US20080044390A1
(en)
|
2006-08-11 |
2008-02-21 |
Xiaowei Jin |
Methods and compositions for the treatment of neurodegenerative disorders
|
|
EP2057195A4
(en)
|
2006-08-29 |
2010-05-12 |
Forhumantech Co Ltd |
PHARMACEUTICAL COMPOSITION FOR THE SUPPRESSION OF APOPTOSIS AND METHOD OF ADMINISTERING THE SAME
|
|
TW200831479A
(en)
*
|
2006-09-26 |
2008-08-01 |
Cytrx Corp |
Pharmaceutical compositions and methods for treating diseases
|
|
MX2009005798A
(es)
|
2006-12-01 |
2009-08-12 |
Cytrx Corp |
Recuperacion de apoplejia.
|
|
WO2008103993A2
(en)
|
2007-02-23 |
2008-08-28 |
University Of Florida Research Foundation, Inc. |
Compositions and methods for treating glycogen storage diseases
|
|
EP2155197A4
(en)
|
2007-03-09 |
2011-10-12 |
Link Medicine Corp |
TREATMENT OF LYSOSOMAL STORAGE DISEASES
|
|
GB0705626D0
(en)
|
2007-03-23 |
2007-05-02 |
Royal Veterinary College |
Method for enhancing sperm survival
|
|
US20100168016A1
(en)
|
2007-04-11 |
2010-07-01 |
The Jackson Laboratory |
Diagnosis and treatment of diseases caused by misfolded proteins
|
|
MX2009011055A
(es)
|
2007-04-13 |
2010-01-13 |
Amicus Therapeutics Inc |
Tratamiento de la enfermedad de gaucher con chaperonas farmacologicas especificas y supervision del tratamiento utilizando marcadores sustitutos.
|
|
KR101691876B1
(ko)
|
2007-04-25 |
2017-01-02 |
사이토크로마 인코포레이티드 |
비타민 ｄ 화합물과 밀랍성 담체를 포함하는 경구 조절성 방출 조성물
|
|
ES2963291T3
(es)
|
2007-04-26 |
2024-03-26 |
Sublimity Therapeutics Ltd |
Fabricación de múltiples minicápsulas
|
|
AU2008245578A1
(en)
|
2007-04-26 |
2008-11-06 |
Amicus Therapeutics, Inc. |
Dosing regimens for the treatment of lysosomal storage diseases using pharmacological chaperones
|
|
TW200901958A
(en)
*
|
2007-05-04 |
2009-01-16 |
Cytrx Corp |
Diabetic wound healing
|
|
GB0712494D0
(en)
|
2007-06-27 |
2007-08-08 |
Isis Innovation |
Substrate reduction therapy
|
|
US7678764B2
(en)
|
2007-06-29 |
2010-03-16 |
Johnson & Johnson Regenerative Therapeutics, Llc |
Protein formulations for use at elevated temperatures
|
|
CN101801402B
(zh)
|
2007-07-06 |
2013-08-28 |
乌得勒支大学控股有限公司 |
炎性疾病和自身免疫疾病的治疗和预防
|
|
WO2009036349A1
(en)
|
2007-09-12 |
2009-03-19 |
Anaphore, Inc. |
Hsp70-based treatment for autoimmune diseases
|
|
US20100317690A1
(en)
|
2007-11-21 |
2010-12-16 |
Summit Corporation Plc |
Treatment of protein folding disorders
|
|
EP2211856A4
(en)
|
2007-11-29 |
2011-02-09 |
Hospital For Sick Children |
COMPOSITIONS AND METHODS FOR TREATING LYSOSOMAL DISORDER
|
|
WO2009099552A2
(en)
|
2008-01-30 |
2009-08-13 |
Corning Incorporated |
Cell culture article and screening
|
|
WO2009095452A1
(en)
|
2008-01-31 |
2009-08-06 |
Crystax Pharmaceuticals, S.L. |
Crystal structure of the atpase domain of proteins of the hsp70 family
|
|
CA2712593A1
(en)
|
2008-02-01 |
2009-08-13 |
The Scripps Research Institute |
Methods for treating a condition characterized by dysfunction in protein homeostasis
|
|
WO2009137721A2
(en)
|
2008-05-07 |
2009-11-12 |
Zystor Therapeutics, Inc. |
Lysosomal targeting peptides and uses thereof
|
|
WO2009137796A2
(en)
|
2008-05-08 |
2009-11-12 |
Northwestern University |
Method of regulating the heat shock response
|
|
GB0809360D0
(en)
|
2008-05-22 |
2008-07-02 |
Isis Innovation |
Calcium modulation
|
|
JP5616336B2
(ja)
|
2008-06-26 |
2014-10-29 |
オルファザイム エーピーエスＯｒｐｈａｚｙｍｅ Ａｐｓ |
酵素活性の調節因子としてのＨｓｐ７０の使用
|
|
US20110237538A1
(en)
|
2008-08-06 |
2011-09-29 |
Summit Corporation Plc |
Treatment of lysosomal storage disorders and other proteostatic diseases
|
|
WO2010022461A1
(en)
|
2008-08-29 |
2010-03-04 |
Children, Youth And Women's Health Service |
Sulphated sugars to increase activity of sulphatases en lysosomal storage disorders
|
|
WO2010037066A2
(en)
|
2008-09-29 |
2010-04-01 |
Vertex Pharmaceuticals Incorporated |
Dosage units of 3-(6-(1-(2,2-difluorobenzo [d] [1,3] dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid
|
|
WO2010053655A2
(en)
|
2008-11-07 |
2010-05-14 |
University Of Kansas |
Therapeutic methods with withaferin a and analogs
|
|
WO2010086418A1
(en)
|
2009-01-29 |
2010-08-05 |
Alfa Biogene International B.V. |
Functional food product comprising heat shock protein or a hydrolysate thereof
|
|
EP2218458A1
(en)
|
2009-02-13 |
2010-08-18 |
Fondazione Telethon |
Molecules able to modulate the expression of at least a gene involved in degradative pathways and uses thereof
|
|
WO2010102988A1
(en)
|
2009-03-10 |
2010-09-16 |
Alfa Biogene International B.V. |
Skin care product
|
|
GB0906159D0
(en)
|
2009-04-09 |
2009-05-20 |
Summit Corp Plc |
Drug combination for the treatment of proteostatic diseases
|
|
US8785168B2
(en)
|
2009-06-17 |
2014-07-22 |
Biomarin Pharmaceutical Inc. |
Formulations for lysosomal enzymes
|
|
AU2010281403B2
(en)
|
2009-07-28 |
2016-03-10 |
Takeda Pharmaceutical Company Limited |
Compositions and methods for treating Gaucher disease
|
|
US20120156180A1
(en)
|
2009-08-10 |
2012-06-21 |
The Board Of Trustees Of The University Of Illinois |
Compositions and methods for the treatment of krabbe and other neurodegenerative diseases
|
|
US20110081428A1
(en)
|
2009-09-16 |
2011-04-07 |
The Buck Institute For Age Research |
Use of thioflavin-like compounds to increase life span and/or health span
|
|
US8609416B2
(en)
|
2009-12-18 |
2013-12-17 |
Ventria Bioscience |
Methods and compositions comprising heat shock proteins
|
|
US9943489B2
(en)
|
2010-02-03 |
2018-04-17 |
Pharmatwob Ltd. |
Extended release formulations of rasagiline and uses thereof
|
|
EP2568999B1
(en)
*
|
2010-05-11 |
2018-07-11 |
Mallinckrodt Ard Ip Limited |
Acth for treatment of amyotrophic lateral sclerosis
|
|
US20130209549A1
(en)
|
2010-07-21 |
2013-08-15 |
University Of South Florida |
Materials and methods for treating neurodegenerative diseases
|
|
US9662375B2
(en)
*
|
2010-11-30 |
2017-05-30 |
Orphazyme Aps |
Methods for increasing intracellular activity of Hsp70
|
|
WO2013006076A1
(en)
|
2011-07-04 |
2013-01-10 |
New York University |
The use of intranasally administered hsp70 protein to treat neurodegenerative diseases
|
|
EP2763663B1
(en)
|
2011-10-06 |
2017-12-27 |
Novartis AG |
Pharmaceutical compositions comprising 40-o-(2-hydroxy)ethyl-rapamycin
|
|
CA2868484A1
(en)
|
2012-03-28 |
2013-10-03 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Salicylic acid derivatives useful as glucocerebrosidase activators
|
|
HK1214521A1
(zh)
|
2012-11-05 |
2016-07-29 |
Genzyme Corporation |
用於治療蛋白質病的組合物和方法
|
|
US10709700B2
(en)
|
2014-09-15 |
2020-07-14 |
Orphazyme A/S |
Arimoclomol formulation
|
|
WO2018215597A1
(en)
|
2017-05-24 |
2018-11-29 |
Orphazyme A/S |
Heat shock protein inducers and frontotemporal disorders
|